Ray Y. Hachem, M.D.

Peer-Reviewed Articles

1. Abu-Sheih H, Ali FS, Chen E, Mallepally N, Luo W, Lu Y, Foo WC, Qiao W, Okhuysen PC, Adachi J, Hachem RY, Altan M, Jenq RR, Wang Y. Neutropenic Enterocolitis:Clinical Features and Outcomes. Dis Colon Rectum 63(3):381-388, 2020. PMID: 31842164.
2. Sarkis R, Hassan H, Lichaa A, Hachem R. COVID-19 Pandemic in the midst of Lebanon worst financial crisis capital control or captain control?, 2020.
3. Wilson Dib R, Hachem R, Chaftari AM, Ghaly F, Jiang Y, Raad I. Treating Invasive Aspergillosis in patients with Hematologic Malignancy: Diagnostic -Driven Approach versus Empiric Therapies. BMC Infect Dis 18(1):656, 2018. PMID: 3054320.
4. Jamal MA, Hachem RY, Rosenblatt J, McArthur MJ, Felix E, Jiang Y, Tailor RC, Raad I. In vivo biocompatibility and in vitro efficacy of antimicrobial gendine-coated central catheters. Antimicrob Agents Chemother 59(9):5611-8, 2015. e-Pub 2015. PMID: 26124171.
5. Hachem R, Reitzel R, Borne A, Jiang Y, Tinkey P, Uthamanthil R, Chandra J, Ghannoum M, Raad I. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results. Antimicrob Agents Chemother 53(12):5145-9, 2009. e-Pub 2009. PMID: 19805562.

Abstracts

1. Ray Hachem, Tarcila Datoguia, Bilal Siddiqui, Ana Fernández Cruz, Nobuyoshi Mori , Suha Fakhreddine, Dong-Gun Lee, Edward Gorak, Robert Somer, Arvinder Bhinder, Samuel Shelanski, Tomislav Dragivich, Arnaud Bayle , Roy Chemaly, Victor Mulanovich, Javier Adachi, Alexander Malek, Monica Slavin, Ying Jiang, Anne-Marie Chaftari, Issam Raad. Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study. ID Week 2020, Virtual Conference, Online, 2020.
2. Bahgat Z Gerges, PhD; Joel Rosenblatt, PhD; Y-Lan Truong, BS; Ruth A Reitzel, PhD; Ray Hachem, MD; Issam I Raad, MD. Resistance to the Minocycline-Rifampin-Chlorhexidine (MRCH) combination does not emerge in biofilms of Tetracycline and Rifampin resistant bacteria grown on MRCH catheters depleted below antimicrobially effective concentrations. ID Week 2020, Virtual Conference, Online, 2020.
3. Harrys A. Torres, GA Georgios Angelidakis, Ying Jiang, ME Minas Economides, MY Marcel Yibirin, Robert Orlowski MD, Richard Champlin, Srdan Verstovsek, Issam I. Raad. Serologic vs. molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies with and without prior hematopoietic cell transplant recipients. ID Week 2020, Virtual Conference, Online, 2020.
4. Hiba Dagher, Ray Hachem, Anne-Marie Chaftari, Ying Jiang, Shahnoor Ali, Rita Deeba, Shivan Shah, Issam Raad. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. ID Week 2020, Virtual Conference, Online, 2020.
5. Patrick Chaftari, MD; Anne-Marie Chaftari, MD; Ray Hachem, MD; Sai-ching J Yeung, MD; Hiba Dagher; Ying Jiang, MS; Alexandre Malek, MD; Victor E Mulanovich, MD; Issam Raad, MD. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center. ID Week 2020, Virtual Conference, Online, 2020.
6. Anne-Marie Chaftari, Ray Hachem, Alexandre E Malek, Victor Mulanovich, Ariel Szvalb, Ying Jiang, Shahnoor Ali, Rita Deeba, Patrick Chaftari, Issam Raad. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies. ID Week 2020, Virtual Conference, Online, 2020.